Toll-like receptor 4 (TLR4) expression has been investigated in tumor cells or cell lines, including gastric carcinoma, extranodal marginal zone B-cell lymphomas, pituitary epithelial tumor cell lines, hepatocellular carcinoma cells, colon cancer cells and human prostate epithelial PC3 cells. This evidence concerns the gene TLR4 and colonic neoplasm.